Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice

Eur J Prev Cardiol. 2020 Dec;27(19):2358-2361. doi: 10.1177/2047487319901208. Epub 2020 Mar 2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cardiotoxicity / etiology
  • Cardiotoxicity / prevention & control*
  • Disease Models, Animal
  • Doxorubicin / toxicity*
  • Galactosylceramides / pharmacology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Natural Killer T-Cells / drug effects*

Substances

  • Galactosylceramides
  • alpha-galactosylceramide
  • Doxorubicin